BULETINI SHKENCOR

“REALD”

2016,Vol. 2,Issue 1

Epidemiologjia e infeksionit nga Helikobakter Pilor Rezultatet krahasuese të mjekimit me Nexium

Author(s)

Prof. Dr. Sotir Vangjeli, Msc. Rezarta Petani , PhD. Donika Zyberaj
Abstract

In the early 1980-s Warren and Marchall, two Australian physicians, reported the presence of an unidentified gram- negativ curved and spiral-shaped bacillus in gastric epithelial tissue of patients with chronic gastritis. Originally called Campylobacter pylori, this organism was later renamed helicobacter pylori when the organism was found to have characteristics that differed from those of true campylobacters. It is now generally accepted that infection with H. pylori is an important cause of peptic ulcer disease and that eradication of this organism greatly reduces the recurrence rate of ulcers. H. pylori also can cause chronic gastritis and hypochlorhydria and is a risk factor for gastritis cancer. Conventional eradication therapies, which consist of two antibiotics plus either a proton-pump inhibitor is highly effective. In this study the authors aim to public the results of a prospective study of many years (1999-2007) of Helicobacter Pylor infection in district of Vlora, according to age and sex, as well to obtain an information to treatment they with Essomeprasol (Nexium), for eradication of this infection. The authors to value in comparative and gastric pathologies to use of anti- inflammations remands non steroids. In this study to be analyzed attentively the nears and distances results of treatment with Esomeprazole, to stand out brilliants results to the eradication of H. P as well low effication in the treatment medicaments gastropathologyes.